Santopaolo, Francesco
 Distribuzione geografica
Continente #
AS - Asia 1.178
NA - Nord America 907
EU - Europa 719
SA - Sud America 282
AF - Africa 42
OC - Oceania 1
Totale 3.129
Nazione #
US - Stati Uniti d'America 860
SG - Singapore 577
CN - Cina 291
BR - Brasile 229
IT - Italia 226
SE - Svezia 96
VN - Vietnam 76
DE - Germania 74
FR - Francia 72
IE - Irlanda 62
IN - India 52
GB - Regno Unito 40
ID - Indonesia 40
HK - Hong Kong 34
FI - Finlandia 32
AR - Argentina 24
KR - Corea 24
CA - Canada 21
RU - Federazione Russa 21
NL - Olanda 18
MX - Messico 17
AT - Austria 16
ZA - Sudafrica 16
IQ - Iraq 14
PL - Polonia 12
BD - Bangladesh 11
JP - Giappone 11
CZ - Repubblica Ceca 10
ES - Italia 10
EC - Ecuador 8
LT - Lituania 7
TR - Turchia 7
SA - Arabia Saudita 6
CI - Costa d'Avorio 5
MA - Marocco 5
PE - Perù 5
PY - Paraguay 5
TZ - Tanzania 5
UY - Uruguay 5
CH - Svizzera 4
CR - Costa Rica 4
PK - Pakistan 4
BY - Bielorussia 3
KG - Kirghizistan 3
PH - Filippine 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
DZ - Algeria 2
ET - Etiopia 2
HU - Ungheria 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
MY - Malesia 2
PA - Panama 2
RO - Romania 2
SN - Senegal 2
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
CG - Congo 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
IM - Isola di Man 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
OM - Oman 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 3.129
Città #
Singapore 301
Ashburn 109
Chandler 107
Hefei 73
Milan 73
Dublin 60
Beijing 59
Rome 54
New York 48
Dallas 43
Los Angeles 37
Hong Kong 34
Jakarta 34
Frankfurt am Main 28
São Paulo 28
Ho Chi Minh City 26
Kent 23
Seoul 23
Hyderabad 20
The Dalles 20
Boardman 18
Boston 16
Denver 14
Hanoi 14
Lappeenranta 13
Moscow 13
Munich 13
Düsseldorf 11
Johannesburg 11
Princeton 11
San Francisco 11
Tokyo 11
Chicago 10
Turku 10
Helsinki 9
Nuremberg 9
Poplar 9
Pune 9
Warsaw 9
Amsterdam 8
Arezzo 8
Stockholm 8
Haiphong 7
Lauterbourg 7
Marseille 7
Montreal 7
Portsmouth 7
Santa Clara 7
Bologna 6
London 6
Mexico City 6
North Bergen 6
Orem 6
Rio de Janeiro 6
Vienna 6
Abidjan 5
Baghdad 5
Bexley 5
Brasília 5
Bremen 5
Brno 5
Buffalo 5
Cimitile 5
Guarulhos 5
Paris 5
Quanzhou 5
Castel di Sangro 4
Chennai 4
Da Nang 4
Dhaka 4
Guayaquil 4
Macapá 4
Newark 4
Phoenix 4
Porto Alegre 4
Riyadh 4
Roubaix 4
Seattle 4
Secaucus 4
Toronto 4
Washington 4
Asunción 3
Atlanta 3
Augusta 3
Bishkek 3
Brdo 3
Buenos Aires 3
Cernusco sul Naviglio 3
Cleveland 3
Coreno Ausonio 3
Council Bluffs 3
Curitiba 3
Dar es Salaam 3
Delhi 3
Erbil 3
Houston 3
Hải Dương 3
Ipatinga 3
Itaquaquecetuba 3
Kozhikode 3
Totale 1.701
Nome #
Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection 135
Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part II - Solid lesions 112
Dynamics of liver stiffness predicts complications in patients with HCV related cirrhosis treated with direct-acting antivirals 109
Missed linkage to care for patients who screened positive for Hepatitis C in a tertiary care centre: Results of the Telepass project 106
Direct portal pressure gradient measurement in patients with porto-sinusoidal vascular disease 95
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 92
Gut microbiota modulation in patients with non-alcoholic fatty liver disease: Effects of current treatments and future strategies 90
ADAMTS-13/von Willebrand factor ratio: A prognostic biomarker for portal vein thrombosis in compensated cirrhosis. A prospective observational study 87
Durvalumab: an investigational agent for unresectable hepatocellular carcinoma 84
Assessing Baveno VI criteria with liver stiffness measured using a new point-shear wave elastography technique (BAVElastPQ study) 80
Management of Portal Hypertension in Patients with Hepatocellular Carcinoma on Systemic Treatment: Current Evidence and Future Perspectives 78
Exploring the link: Porto-sinusoidal vascular disorder and inflammatory bowel disease - A comprehensive narrative review 76
Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis 75
Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties 75
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship 75
Correlation Between Liver Function Tests Abnormalities and Interleukin-6 Serum Levels in Patients With SARS-CoV-2 Infection 75
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 73
Advances in pharmacotherapeutics for hepatocellular carcinoma 73
The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence 72
Multiparametric Dynamic Ultrasound Approach for Differential Diagnosis of Primary Liver Tumors 72
From coagulation imbalance to prediction of advanced chronic liver disease decompensation: the wind of change? 71
Fecal microbiota transplantation in patients with hbv infection or other chronic liver diseases: Update on current knowledge and future perspectives 71
Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection 69
Low seroprevalence of SARS-CoV-2 antibodies in cirrhotic patients 69
SIRT in 2025 68
Liver Decompensation in Patients With Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab: A Real-life Study 67
Cellular therapies in liver and pancreatic diseases 67
Bariatric surgery and liver disease: General considerations and role of the gut–liver axis 67
The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases 65
Late HBV reactivation after hematopoietic stem cell transplantation, despite long-term prophylaxis 63
Type 2 Diabetes Mellitus and Liver Disease: Across the Gut-Liver Axis from Fibrosis to Cancer 63
Non-Invasive Biomarkers for Immunotherapy in Patients with Hepatocellular Carcinoma: Current Knowledge and Future Perspectives 63
Endotoxemia and Gastrointestinal Cancers: Insight into the Mechanisms Underlying a Dangerous Relationship 62
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 62
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment 61
Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows 61
Low ADAMTS-13/VWF ratio and altered gut-liver axis predict complications of advanced chronic liver disease: a pilot study 61
Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis 59
Letter: liver involvement and mortality in COVID-19 patients – authors' reply 59
Risk factors for portal vein thrombosis or venous thromboembolism in a large cohort of hospitalized cirrhotic patients 59
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 56
Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications 55
Benign liver lesions 2022: Guideline for clinical practice of Associazione Italiana Studio del Fegato (AISF), Società Italiana di Radiologia Medica e Interventistica (SIRM), Società Italiana di Chirurgia (SIC), Società Italiana di Ultrasonologia in Medicina e Biologia (SIUMB), Associazione Italiana di Chirurgia Epatobilio-Pancreatica (AICEP), Società Italiana Trapianti d'Organo (SITO), Società Italiana di Anatomia Patologica e Citologia Diagnostica (SIAPEC-IAP) – Part I – Cystic lesions 51
Totale 3.183
Categoria #
all - tutte 15.926
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202245 0 0 0 0 0 0 0 0 3 1 18 23
2022/2023327 38 36 16 41 14 36 13 37 39 6 17 34
2023/2024405 19 91 19 23 34 69 32 8 5 23 32 50
2024/2025993 17 17 88 27 59 41 52 63 127 105 234 163
2025/20261.413 301 126 220 342 403 21 0 0 0 0 0 0
Totale 3.183